Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ashwath Jayagopal Insider Profile
4 Followers
Ashwath Jayagopal, Chief Scientific & Dev. Ofc at Ocuphire Pharma, holds 78.50K shares in Ocuphire Pharma (Ticker: OCUP). Most recently, Ashwath Jayagopal Bought $3,500 shares of Ocuphire Pharma on May 24, 2024 for an estimated value of 6.16K.
Ashwath Jayagopal has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ashwath Jayagopal's holdings
Insider Roles
Chief Scientific & Dev. Ofc
Roles that Ashwath Jayagopal holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ashwath Jayagopal
Ashwath Jayagopal's Trading History
List of latest transactions for each holding click on a transaction to see Ashwath Jayagopal's performance on stock
You May Also Like
Ashwath Jayagopal insider profile FAQ
What is the percentage of profitable transactions made by Ashwath Jayagopal?
The percentage of profitable transactions made by Ashwath Jayagopal is ―.
What is the average return per transaction made by Ashwath Jayagopal?
The average return per transaction made by Ashwath Jayagopal is ―.
What stocks does Ashwath Jayagopal hold?
Ashwath Jayagopal holds: OCUP stocks.
What was Ashwath Jayagopal’s latest transaction?
Ashwath Jayagopal latest transaction was an Informative Buy of $6.16K.
What was Ashwath Jayagopal's most profitable transaction?
Ashwath Jayagopal’s most profitable transaction was an Informative Buy of OCUP stock on May 24, 2024. The return on the trade was 13.00%.
What is Ashwath Jayagopal's role in Ocuphire Pharma?
Ashwath Jayagopal's role in Ocuphire Pharma is Chief Scientific & Dev. Ofc.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.